The Full Wiki

Dystrophin: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Dystrophin (muscular dystrophy, Duchenne and Becker types)

PDB rendering based on 1dxx.
Available structures
1dxx, 1eg3, 1eg4
Symbols DMD; BMD; CMD3B; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
External IDs OMIM300377 MGI94909 HomoloGene20856 GeneCards: DMD Gene
RNA expression pattern
PBB GE DMD 203881 s at tn.png
PBB GE DMD 208086 s at tn.png
More reference expression data
Species Human Mouse
Entrez 1756 13405
Ensembl ENSG00000198947 ENSMUSG00000045103
UniProt P11532 Q3TWL4
RefSeq (mRNA) NM_000109 NM_007868
RefSeq (protein) NP_000100 NP_031894
Location (UCSC) Chr X:
31.05 - 33.27 Mb
Chr X:
79.39 - 81.45 Mb
PubMed search [1] [2]

Dystrophin is a rod-shaped cytoplasmic protein, and a vital part of a protein complex that connects the cytoskeleton of a muscle fiber to the surrounding extracellular matrix through the cell membrane. This complex is variously known as the costamere or the dystrophin-associated protein complex. Many muscle proteins, such as α-dystrobrevin, syncoilin, synemin, sarcoglycan, dystroglycan, and sarcospan, colocalize with dystrophin at the costamere.

As of 2007, dystrophin is the longest gene known, covering 2.4 megabases (0.08% of the human genome) at locus Xp21. The primary transcript measures about 2,400 kilobases and takes 16 hours to transcribe; the mature mRNA measures 14.0 kilobases[1]. The 79 exons[2] code for a protein of over 3500 amino acid residues.[3]



Dystrophin deficiency has been definitively established as one of the root causes of the general class of myopathies collectively referred to as muscular dystrophy. The large cytosolic protein was first identified in 1987 by Louis M. Kunkel [4], after the 1986 discovery of the mutated gene that causes Duchenne muscular dystrophy (DMD) [5].

Normal skeletal muscle tissue contains only small amounts of dystrophin (about 0.002% of total muscle protein), but its absence (or abnormal expression) leads to the development of a severe and currently incurable constellation of symptoms most readily characterized by several aberrant intracellular signaling pathways that ultimately yield pronounced myofiber necrosis as well as progressive muscle weakness and fatigability. Most DMD patients become wheelchair-dependent early in life, and the gradual development of cardiac hypertrophy—a result of severe myocardial fibrosis—typically results in premature death in the first two or three decades of life. Mutations in the dystrophin gene that lead to the production of less defective, but still only partially functional dystrophin protein, result in a display of a much milder dystrophic phenotype in affected patients, resulting in the disease known as Becker's muscular dystrophy (BMD). In some cases the patient's phenotype is such that experts may decide differently on whether a patient should be diagnosed with DMD or BMD. The theory currently most commonly used to predict whether a mutation will result in a DMD or BMD phenotype, is the reading frame rule.[6]

Though its role in airway smooth muscle is not well established, recent research indicates that dystrophin along with other subunits of dystrophin glycoprotein complex is associated with phenotype maturation.[7]


Dystrophin has been shown to interact with SNTB1,[8] Syntrophin, alpha 1[9][10][11] and DTNA.[12]


  1. ^ NCBI Sequence Viewer v2.0
  2. ^ Strachan T and Read AP, 1999. Human molecular genetics, BIOS Scientific, New York, USA
  3. ^ NCBI Sequence Viewer v2.0
  4. ^ Hoffman E, Brown R, Kunkel L (1987). "Dystrophin: the protein product of the Duchenne muscular dystrophy locus". Cell 51 (6): 919–28. doi:10.1016/0092-8674(87)90579-4. PMID 3319190.  
  5. ^ Monaco A, Neve R, Colletti-Feener C et al. (1986). "Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene". Nature 323 (6089): 646–50. doi:10.1038/323646a0. PMID 3773991.  
  6. ^ Aartsma-Rus A, et al. (2006). "Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule". Muscle Nerve 34 (2): 135–44. PMID 16770791.  
  7. ^ Sharma P, Tran T, Stelmack GL, et al. (2008). "Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation". Am. J. Physiol. Lung Cell Mol. Physiol. 294 (1): L57–68. doi:10.1152/ajplung.00378.2007. PMID 17993586.  
  8. ^ Ahn, A H; Kunkel L M (Feb. 1995). "Syntrophin binds to an alternatively spliced exon of dystrophin". J. Cell Biol. (UNITED STATES) 128 (3): 363–71. ISSN 0021-9525. PMID 7844150.  
  9. ^ Ahn, A H; Freener C A, Gussoni E, Yoshida M, Ozawa E, Kunkel L M (Feb. 1996). "The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives". J. Biol. Chem. (UNITED STATES) 271 (5): 2724–30. ISSN 0021-9258. PMID 8576247.  
  10. ^ Yang, B; Jung D, Rafael J A, Chamberlain J S, Campbell K P (Mar. 1995). "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin". J. Biol. Chem. (UNITED STATES) 270 (10): 4975–8. ISSN 0021-9258. PMID 7890602.  
  11. ^ Gee, S H; Madhavan R, Levinson S R, Caldwell J H, Sealock R, Froehner S C (Jan. 1998). "Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins". J. Neurosci. (UNITED STATES) 18 (1): 128–37. ISSN 0270-6474. PMID 9412493.  
  12. ^ Sadoulet-Puccio, H M; Rajala M, Kunkel L M (Nov. 1997). "Dystrobrevin and dystrophin: an interaction through coiled-coil motifs". Proc. Natl. Acad. Sci. U.S.A. (UNITED STATES) 94 (23): 12413–8. ISSN 0027-8424. PMID 9356463.  

Further reading

  • Roberts RG, Gardner RJ, Bobrow M (1994). "Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations". Hum. Mutat. 4 (1): 1–11. doi:10.1002/humu.1380040102. PMID 7951253.  
  • Tinsley JM, Blake DJ, Zuellig RA, Davies KE (1994). "Increasing complexity of the dystrophin-associated protein complex". Proc. Natl. Acad. Sci. U.S.A. 91 (18): 8307–13. doi:10.1073/pnas.91.18.8307. PMID 8078878.  
  • Blake DJ, Weir A, Newey SE, Davies KE (2002). "Function and genetics of dystrophin and dystrophin-related proteins in muscle". Physiol. Rev. 82 (2): 291–329. doi:10.1152/physrev.00028.2001 (inactive 2008-06-22). PMID 11917091.  
  • Röper K, Gregory SL, Brown NH (2003). "The 'spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families". J. Cell. Sci. 115 (Pt 22): 4215–25. doi:10.1242/jcs.00157. PMID 12376554.  
  • Muntoni F, Torelli S, Ferlini A (2003). "Dystrophin and mutations: one gene, several proteins, multiple phenotypes". Lancet neurology 2 (12): 731–40. doi:10.1016/S1474-4422(03)00585-4. PMID 14636778.  
  • Haenggi T, Fritschy JM (2006). "Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue". Cell. Mol. Life Sci. 63 (14): 1614–31. doi:10.1007/s00018-005-5461-0. PMID 16710609.  

External links



Got something to say? Make a comment.
Your name
Your email address